NVIDIA Bets on Sovereign AI: Will It Shield Against Trade War?
Sovereign AI refers to countries building their own national AI infrastructure, using trusted platforms to protect data, boost innovation and maintain control over their AI systems. NVIDIA is playing a key role in these efforts. It has announced major AI factory projects in Saudi Arabia, where it plans to deliver 18,000 AI chips.
In Europe, it has received strong backing from leaders in France and Germany for its sovereign AI projects. The European Union is aggressively investing in AI with a planned investment of $20 billion to build four AI gigafactories across the region. The company is also partnering with firms like Foxconn and local governments to build AI infrastructure in Taiwan and the UAE. This bodes well for NVIDIA's sovereign AI initiative.
Sovereign AI gives NVIDIA a chance to build long-term partnerships in regions not affected by China-related trade controls. These projects will rely on NVIDIA's full-stack solution, including graphics processing units (GPUs), networking tools (like NVLink and Spectrum-X), software platforms (such as CUDA and NeMo) and AI services. Once adopted, this system is hard to replace due to the massive capital investment.
While sovereign AI won't fully replace the scale of China's market, it gives NVIDIA access to new territories that want to develop AI infrastructure locally. This could help balance the impact of trade restrictions and support NVIDIA's long-term growth.
Two competitors, Advanced Micro Devices, Inc. AMD and Intel Corporation INTC, are also trying to grow in the AI infrastructure space. However, they are far behind NVIDIA when it comes to sovereign AI projects.
Advanced Micro Devices is gaining attention with its Instinct MI300X chips, which are designed for large AI workloads. Some major cloud companies like Microsoft and Meta are testing AMD's GPUs. However, Advanced Micro Devices does not yet offer a full-stack solution like NVIDIA. It lacks networking hardware and software tools at the same level as NVIDIA owns.
Intel is promoting its Gaudi 3 AI chips as a low-cost option for training and inference. However, Intel's AI ecosystem is still developing, and its overall AI market share remains small. It also does not offer a complete package that ties chips, software and networking together.
Both companies are making progress, but NVIDIA's complete system gives it a strong lead.
Shares of NVIDIA have risen around 19.1% year to date against the Zacks Computer and Technology sector's gain of 7%.
Image Source: Zacks Investment Research
From a valuation standpoint, NVDA trades at a forward price-to-earnings ratio of 33.13, higher than the sector's average of 27.37.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for NVIDIA's fiscal 2026 and 2027 earnings implies a year-over-year increase of approximately 41.8% and 31.9%, respectively. Estimates for fiscal 2026 have remained unchanged over the past 60 days, while those for fiscal 2027 have been revised upward in the past 30 days.
Image Source: Zacks Investment Research
NVIDIA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intel Corporation (INTC) : Free Stock Analysis Report
Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
High Growth Tech Stocks In Asia Featuring Ningbo Yunsheng And Two More
As global markets continue to navigate a complex landscape, the Asian tech sector is capturing attention with its dynamic growth potential amidst mixed economic signals. In this context, identifying promising stocks involves looking for companies that demonstrate resilience and innovation, such as Ningbo Yunsheng and others that thrive despite broader market fluctuations. Name Revenue Growth Earnings Growth Growth Rating Suzhou TFC Optical Communication 30.19% 29.63% ★★★★★★ Shengyi Electronics 22.99% 35.16% ★★★★★★ Range Intelligent Computing Technology Group 27.31% 28.63% ★★★★★★ Shanghai Huace Navigation Technology 24.44% 23.48% ★★★★★★ PharmaResearch 26.50% 29.34% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ Global Security Experts 20.56% 28.04% ★★★★★★ CARsgen Therapeutics Holdings 81.53% 96.08% ★★★★★★ Marketingforce Management 26.39% 112.30% ★★★★★★ JNTC 55.45% 94.52% ★★★★★★ Click here to see the full list of 478 stocks from our Asian High Growth Tech and AI Stocks screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ningbo Yunsheng Co., Ltd. focuses on the research, development, manufacture, and sale of rare earth permanent magnet materials in China with a market capitalization of CN¥12.67 billion. Operations: The company generates revenue primarily from the sale of Neodymium Iron Boron materials, totaling CN¥5.14 billion. Ningbo Yunsheng's recent pivot into profitability, with a net income of CN¥95.08 million from a prior loss, underscores its resilience and adaptability in the tech sector. This turnaround is highlighted by an impressive annual revenue growth rate of 17.8% and even more robust earnings growth at 39.8% per year, outpacing the broader Chinese market's average. The firm's commitment to innovation is evident from its R&D investments, ensuring it stays relevant amidst rapid technological advancements. With these strong financials and strategic focus on research and development, Ningbo Yunsheng appears well-positioned for sustained growth in Asia's competitive high-tech landscape. Click here and access our complete health analysis report to understand the dynamics of Ningbo Yunsheng. Explore historical data to track Ningbo Yunsheng's performance over time in our Past section. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Beijing Zhong Ke San Huan High-Tech Co., Ltd. operates in the high-tech industry with a market cap of CN¥14.79 billion. Operations: Beijing Zhong Ke San Huan High-Tech Co., Ltd. specializes in the high-tech sector, focusing on advanced materials and technology solutions. The company generates revenue through its diverse product offerings, catering to various industrial applications. Beijing Zhong Ke San Huan High-Tech has demonstrated a notable turnaround, with its first-quarter net income reaching CN¥13.49 million, a significant recovery from the previous year's loss. This improvement is anchored by robust earnings growth of 43.9% annually and an impressive revenue increase of 19.9% per year, signaling strong market demand and operational efficiency. Despite facing challenges like a recent dividend cut to CN¥0.20 per share, the company's strategic focus on R&D—evident from substantial investments—positions it well within Asia's dynamic tech landscape to leverage emerging technological trends effectively. Click to explore a detailed breakdown of our findings in Beijing Zhong Ke San Huan High-Tech's health report. Gain insights into Beijing Zhong Ke San Huan High-Tech's past trends and performance with our Past report. Simply Wall St Growth Rating: ★★★★★☆ Overview: Pansoft Company Limited offers management information solutions and IT integrated services for large enterprises in China, with a market cap of CN¥5.34 billion. Operations: Pansoft specializes in delivering management information solutions and IT integrated services to large enterprises across China. The company focuses on leveraging its expertise to support enterprise-level clients with tailored technological solutions. Pansoft, amidst a dynamic phase of corporate restructuring, has recently seen significant changes including amendments to its articles of association and adjustments in its registered capital, reflecting a strategic pivot aimed at enhancing governance and operational flexibility. Despite experiencing a downturn with a net loss of CN¥13.95 million in the first quarter of 2025 from a prior profit, the company's aggressive approach towards R&D investment aligns with its long-term vision to stabilize and eventually expand within the high-tech sector in Asia. Notably, Pansoft's revenue growth forecast at 21.1% annually surpasses China's market average by nearly 9%, coupled with an anticipated earnings surge of 32.2% per year—outpacing the broader market's expectation by almost 9%. This robust financial trajectory, backed by substantial reinvestment in innovation and technology development, positions Pansoft to potentially leverage emerging tech trends effectively despite current volatility. Delve into the full analysis health report here for a deeper understanding of Pansoft. Understand Pansoft's track record by examining our Past report. Delve into our full catalog of 478 Asian High Growth Tech and AI Stocks here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:600366 SZSE:000970 and SZSE:300996. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
High Growth Tech Stocks in Asia Featuring Vobile Group and Two Others
As global markets continue to navigate a landscape marked by mixed economic signals, with U.S. small-cap indexes like the S&P MidCap 400 and Russell 2000 showing notable gains, investors are closely watching Asian tech stocks for potential growth opportunities. In this dynamic environment, identifying high-growth tech stocks in Asia requires a keen understanding of market trends and economic indicators that can influence performance, such as innovation capabilities and adaptability to shifting trade policies. Name Revenue Growth Earnings Growth Growth Rating Shengyi Electronics 22.99% 35.16% ★★★★★★ Fositek 28.67% 35.10% ★★★★★★ Shanghai Huace Navigation Technology 24.44% 23.48% ★★★★★★ Range Intelligent Computing Technology Group 27.31% 28.63% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ PharmaResearch 25.04% 26.89% ★★★★★★ Global Security Experts 20.56% 28.04% ★★★★★★ CARsgen Therapeutics Holdings 81.05% 87.21% ★★★★★★ Marketingforce Management 26.39% 112.30% ★★★★★★ JNTC 55.45% 94.52% ★★★★★★ Click here to see the full list of 487 stocks from our Asian High Growth Tech and AI Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Vobile Group Limited is an investment holding company that offers software as a service for digital content asset protection and transactions across the United States, Mainland China, and internationally, with a market cap of HK$8.46 billion. Operations: The company generates revenue primarily through its SaaS offerings for digital content asset protection and transactions, amounting to HK$2.40 billion. Vobile Group's strategic moves, including a recent alliance with Shanghai Film Group and several equity offerings totaling over HKD 1 billion, underscore its aggressive expansion in digital cultural content. This growth trajectory is supported by a notable 23% revenue increase in Q1 2025 compared to the previous year, with mainland China revenues up by 21%. The company's commitment to innovation is evident from its investment in R&D, crucial for staying competitive in the fast-evolving tech landscape. Despite challenges like lower than industry average return on equity projections (13.6%), Vobile's earnings are expected to surge by 28.55% annually, outpacing the Hong Kong market forecast of 10.3%. This blend of strategic partnerships and robust financial performance positions Vobile as a dynamic player in Asia's tech scene, albeit with areas requiring careful navigation to maintain momentum. Get an in-depth perspective on Vobile Group's performance by reading our health report here. Learn about Vobile Group's historical performance. Simply Wall St Growth Rating: ★★★★★☆ Overview: Zhejiang Top Cloud-agri Technology Co., Ltd. operates in the agricultural technology sector, focusing on innovative solutions and has a market capitalization of CN¥7.96 billion. Operations: Zhejiang Top Cloud-agri Technology Co., Ltd. specializes in the agricultural technology sector, offering innovative solutions to enhance farming practices. The company generates revenue through its advanced technological products and services designed for agriculture, contributing significantly to its market presence. Zhejiang Top Cloud-agri Technology, despite its niche focus on agricultural tech, is making significant strides in the high-growth tech sector in Asia. With a robust 26.4% annual revenue growth and an even more impressive projected earnings increase of 29% per year, the company is outperforming many regional counterparts. Recent affirmations of dividends at CNY 5.865 per 10 shares highlight financial stability and shareholder confidence. Additionally, amendments to its bylaws reflect a dynamic approach to governance, aligning with its innovative drive in deploying advanced technologies for agricultural enhancements. This strategic positioning not only underscores its commitment to growth but also enhances its potential in a critical sector that bridges technology with sustainable farming practices. Dive into the specifics of Zhejiang Top Cloud-agri TechnologyLtd here with our thorough health report. Evaluate Zhejiang Top Cloud-agri TechnologyLtd's historical performance by accessing our past performance report. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Future Corporation is a Japanese company specializing in IT consulting and services, with a market cap of ¥201.54 billion. Operations: The company generates revenue primarily through its IT Consulting & Services segment, which includes package software and services, contributing ¥63.38 billion. Business Innovation adds another ¥8.85 billion to the total revenue stream. Future Corporation is positioning itself as a resilient contender in Asia's tech industry, with its board recently resolving to utilize treasury stock for strategic equity plans, signaling confidence in its financial health and governance. This move coincides with an uptick in dividend payouts to JPY 23.00 per share, reflecting a robust financial strategy amidst a forecasted annual revenue growth of 9.9% and earnings growth of 13.9%. Notably, the company's R&D commitment is underscored by significant investments aimed at fostering innovation and maintaining competitive advantage in a rapidly evolving market landscape. These strategic decisions are set against a backdrop of solid performance metrics such as an expected operating profit of JPY 16,050 million for the fiscal year ending December 2025, illustrating Future's adept navigation through tech sector challenges while capitalizing on growth opportunities. Unlock comprehensive insights into our analysis of Future stock in this health report. Gain insights into Future's historical performance by reviewing our past performance report. Gain an insight into the universe of 487 Asian High Growth Tech and AI Stocks by clicking here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:3738 SZSE:301556 and TSE:4722. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Newly Elected Directors of Sinovac Hold the First Board Meeting
Mr. Andrew Y. Yan elected Chairman of the Board New Board Unanimously Resolved to Explore Future Dividend Plans, Conduct Search for New Auditor for Resuming NASDAQ Trading, and Restore Stable Operations of the Company, Amongst Other Things BEIJING, July 10, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan and Mr. Yin Weidong (collectively, the new Directors), held its first meeting today at the Company's headquarters in Beijing. This meeting is the first Board meeting held after the new Directors were elected to the Board at the Special Meeting of the Company held on July 8, 2025, at 8:00 p.m. Atlantic Standard Time. At the Special Meeting, 33,248,861 votes (or 54.71% of the total votes present and voting at the Special Meeting) were voted in favor of the election of the new Directors. The meeting was attended by eight of the ten new Directors, and another new Director who was absent from the meeting due to a schedule conflict expressed his support for the Board. As the first item on the agenda, the Directors elected Mr. Andrew Y. Yan, Managing Partner of SAIF Partners, as the Chairman of the Board. Throughout the meeting, the Board stressed its unwavering commitment to shareholder value creation and its intent to explore future dividend plans. Further, as the first steps to rectify the disruptions and chaos created by the previous board of the Company, the Board unanimously resolved that it will work diligently with the management and the advisors of the Company to appoint a new auditor of the Company so that the trading of the Company's shares on NASDAQ can be resumed as soon as possible, to properly and legally resolve the Company's ongoing litigations with shareholders, and to take necessary steps to defend the election results of the Special Meeting and restore stable operations of the Company. To this end, the Board declared that no individual or entity shall be entitled to represent the Company unless they are properly authorized by the Board or the management. At the meeting, the Board confirmed that Mr. Yin Weidong shall continue to serve as Executive Director and Chief Executive Officer of the Company. The Board thanked the current management for their extraordinary efforts in the past few years in navigating the Company through various challenges and confirmed its support of the current management to continue to lead the Company. Mr. Yin Weidong thanked the Board for its trust and expressed his confidence in the Company under the leadership of the Board. Mr. Andrew Y. Yan, Chairman of the SINOVAC Board, commented, "I am honored to be elected Chairman at this pivotal moment in SINOVAC's journey. With the support of our new Board, which fairly represents all shareholders' interest, we are committed to rebuilding trust, enhancing transparency, and delivering long-term value to our shareholders. This marks the beginning of a new era for the Company—one grounded in sound governance, operational excellence, and global ambition. I am confident that, together with management, we will lead SINOVAC into a stronger, more sustainable future." About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. View source version on Contacts Investor and Media Contact Sinovac Biotech ir@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
